Could the next breakthrough in cancer treatment come from combining artificial intelligence (AI) with quantum computing? Researchers at the Technical University of Denmark (DTU) have taken an early step by using a photonic quantum computer to improve how an AI model designs peptides, which help the immune system recognise diseased or infected cells. A quantum computer differs from a normal or classical computer mainly in the way it is built and operates. While the latter uses bits (basic unit of classical information) that are either 0 or 1, a quantum computer uses qubits (fundamental unit of quantum information) that can be both at the same time. A photonic quantum computer uses individual light particles, or photons, as qubits to encode and process information. The DTU’s proof-of-concept study (real-world feasibility test), which is awaiting peer review, confirmed through laboratory tests that the AI-designed peptides could successfully bind to human leukocyte antigen (HLA) molecules present on a cell’s surface — a critical first step in triggering an immune response. Timothy Patrick Jenkins, corresponding author of the study, told The Indian Express that while the technology is still far from clinical use, it could eventually help scientists develop more personalised cancer vaccines and other immune-based therapies. Peptides are short chains of amino acids, the building blocks of proteins. In immunology, they matter because cells display peptides on their surface, allowing your immune system to inspect them and decide what is healthy and what is foreign. Many vaccines work by showing the immune system the right peptide and training it to respond. The human leukocyte antigen (HLA) proteins, sitting on the surface of almost all your cells, are the immune molecules. They act like a display shelf, grabbing short peptides from inside the cell and holding them up on the surface so patrolling immune